July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Astrocyte-Produced Lipoxins Protect Retinal Ganglion Cells from Acute and Chronic Stress
Author Affiliations & Notes
  • izhar Livne-bar
    Vision Science, University Health Network-Krembil Research Institute, Toronto, Ontario, Canada
  • Jessica Wei
    Vision Science Program, UC Berkeley, School of Optometry, Berkeley, California, United States
  • Hsin-Hua Liu
    Vision Science Program, UC Berkeley, School of Optometry, Berkeley, California, United States
  • Samih Alqawlaq
    Vision Science, University Health Network-Krembil Research Institute, Toronto, Ontario, Canada
    Ophthalmology and Vision Science, University of Toronto, Toronto, Ontario, Canada
  • Gah-Jone Won
    Vision Science, University Health Network-Krembil Research Institute, Toronto, Ontario, Canada
  • Alessandra Tuccitto
    Vision Science, University Health Network-Krembil Research Institute, Toronto, Ontario, Canada
    Ophthalmology and Vision Science, University of Toronto, Toronto, Ontario, Canada
  • Karsten Gronert
    Vision Science Program, UC Berkeley, School of Optometry, Berkeley, California, United States
  • John G Flanagan
    Vision Science Program, UC Berkeley, School of Optometry, Berkeley, California, United States
  • Jeremy M Sivak
    Vision Science, University Health Network-Krembil Research Institute, Toronto, Ontario, Canada
    Ophthalmology and Vision Science, University of Toronto, Toronto, Ontario, Canada
  • Footnotes
    Commercial Relationships   izhar Livne-bar, None; Jessica Wei, None; Hsin-Hua Liu, None; Samih Alqawlaq, None; Gah-Jone Won, None; Alessandra Tuccitto, None; Karsten Gronert, None; John Flanagan, None; Jeremy Sivak, None
  • Footnotes
    Support  Support provided by CIHR (MOP123448; JS, JF), NIH (EY026082; KG), NSERC, GRSC (JS), and a GRF Shaffer Grant (HL). JS is the TGWH Foundation Glaucoma Research Chair
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 2614. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      izhar Livne-bar, Jessica Wei, Hsin-Hua Liu, Samih Alqawlaq, Gah-Jone Won, Alessandra Tuccitto, Karsten Gronert, John G Flanagan, Jeremy M Sivak; Astrocyte-Produced Lipoxins Protect Retinal Ganglion Cells from Acute and Chronic Stress. Invest. Ophthalmol. Vis. Sci. 2018;59(9):2614.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Astrocytes play critical homeostatic roles in the CNS and retina. We have demonstrated that quiescent retinal astrocytes promote retinal ganglion cell (RGC) survival in vivo, and that the protective activity is present in the astrocyte-conditioned media (ACM). Here we report that astrocyte-produced lipoxins, a family of secreted small lipid mediators, provide RGC protection from acute insult and elevated intraocular pressure (IOP). This activity includes a direct neuroprotective component that alters mitochondrial membrane potential.

Methods : ACM and control media were analyzed by LC-MS/MS to determine levels of lipid mediator production.In addition, retinal expression of lipoxin producing enzymes and receptors was determined by qPCR and immunofluorescence. Protective activity of the identified lipoxins was tested in vivo by intravitreal injection, in combination with acute kainic acid (KA) injury or sustained elevated IOP through perilimbal suture. RGC survival from the KA and IOP injury was quantified using RGC specific antibodies and functional electroretinogram. RGC survival and mitochondrial membrane potential were quantified in vitro using confocal microscopy.

Results : We established that the two endogenous lipoxins LXA4 and LXB4 are enriched in protective ACM. Following intravitreal injection we found that each lipoxin significantly reduced RGC loss from acute injury, with LXB4 being more potent. Furthermore, inhibition of 5-LOX, a key enzyme for lipoxin biosynthesis, compromised RGC survival, while an antagonist against FPR2, an LXA4 receptor, also reduced survival. Direct neuroprotective activity was observed on cultured RGCs, associated with normalization of mitochondrial membrane potential. Finally, therapeutic LXB4 treatment in a chronic, elevated IOP rat model promoted RGC function and survival.

Conclusions : These data demonstrate that the lipoxins, LXA4 and LXB4, are produced by retinal astrocytes. They exhibit direct neuroprotective activity and their production is reduced following retinal injury. We characterized their biosynthesis and roles in inner retinal injury and discovered higher protective activity for LXB4 which is associated with stabilizing mitochondrial membrane potential. Finally, we demonstrated that therapeutic LXB4 administration is functionally and pathologically efficacious in a chronic glaucoma model.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×